SlideShare a Scribd company logo
1 of 9
Information Article
◦ Received to published : 2 April 2018
◦ Published in a manner on line : 22 May 2018
◦ DOI: https://doi.org/10.1016/j.jotr.2018.05.003
◦ Cost/endorsement :This research did not receive any specific grant from funding agencies in
the public, commercial or not-for-profit sectors, and no material support of any kind was
received.
Filtering to Validity Early and Relevance
1. Isthearticleapeer-reviewedjournal?No
2. Isthisresearchlocation,ifvalid,willbeusedforthebenefitofmypractice?Yes.
3. Whetherthisresearchissponsoredbyanorganizationthatmaybeinvolvedinthe
designoftheresearchdata?No.
Filtering to Validity Early and Relevance
4. Wouldthisinformation,iftrue,haveadirectimpactonthehealthofmypatientsand
willitbemeaningfultothem?Yes.
5. Whetherthisproblemissomethingthatisfrequentlyencounteredinmyplaceof
practice,andwhethertheinterventionortestcanbeusedandisavailableformeto
use?Yes.
6. Wouldthisinformation,ifcorrect,leadmetochangemycurrentpractice?Yes.
Level Therapy/Prevention,
Aetiology/Harm
Prognosis Diagnosis
1 a SR (with homogeneity*) of
RCTs
SR (with homogeneity*) of
inception cohort studies:
CDR± validated in different
populations
SR (with homogeneity*) of
Level 1 diagnostic studies;
CDR± with 1b studies from
different clinical centres
1 b Individual RCT (with narrow
Confidence Interval±)
Individual inception cohort
study with > 80% follow-up;
CDR± validated in a single
population
Validating** cohort study with
good±±± reference
standards; or CDR± tested
within one clinical centre
1 c All or none All or none case-series Absolute SpPins and
SnNouts±±
LEVEL 1 OF EVIDANCE
Level Therapy/Prevention,
Aetiology/Harm
Prognosis Diagnosis
2 a SR (with homogeneity*) of
cohort studies
SR (with homogeneity*) of
either retrospective cohort
studies or untreated control
groups in RCTs
SR (with homogeneity*) of
Level >2 diagnostic studies
2 b Individual cohort study
(including low quality RCT;
e.g., <80% follow- up)
Retrospective cohort study or
follow-up of untreated
control patients in an RCT;
Derivation of CDR± or
validated on split- sample
only
Exploratory** cohort study
with good±±± reference
standards; CDR± after
derivation, or validated only
on split-sample or databases
2 c "Outcomes" Research;
Ecological studies
"Outcomes" Research
LEVEL 2 OF EVIDENCE
Level Therapy/Prevention,
Aetiology/Harm
Prognosis Diagnosis
3 a SR (with homogeneity*) of
cohort studies
SR (with homogeneity*) of 3b
and better studies
3 b Individual Case-Control
Study
Non-consecutive study; or
without consistently applied
reference standards
4 Case-series (and poor
quality cohort and case-
control studies§§)
Case-series (and poor quality
prognostic cohort studies***)
Case-control study, poor or
non-independent reference
standard
5 Expert opinion without
explicit critical appraisal, or
based on physiology, bench
research or "first principles"
Expert opinion without
explicit critical appraisal, or
based on physiology, bench
research or "first principles"
Expert opinion without
explicit critical appraisal, or
based on physiology, bench
research or "first principles"
LEVEL 3,4,5 OF EVIDENCE
A consistent level 1 studies
B consistent level 2 or 3 studies or extrapolations from level 1 studies
C level 4 studies or extrapolations from level 2 or 3 studies
D level 5 evidence or troublingly inconsistent or inconclusive studies pf any level
GRADE OF RECOMENDATION
THANK YOU

More Related Content

Similar to Filtering Medical Research for Validity and Relevance

Methodology Checklist : Studies of Diagnostic Accuracy
Methodology Checklist : Studies of Diagnostic AccuracyMethodology Checklist : Studies of Diagnostic Accuracy
Methodology Checklist : Studies of Diagnostic AccuracyQURATULAIN MUGHAL
 
Surgical_audit_&_research_iagsisbbbuikbb
Surgical_audit_&_research_iagsisbbbuikbbSurgical_audit_&_research_iagsisbbbuikbb
Surgical_audit_&_research_iagsisbbbuikbbYassinAdil1
 
Qi Irb Presentation
Qi Irb PresentationQi Irb Presentation
Qi Irb Presentationhedavidson
 
DATA AND SAFETY MONITORING BOARD.pptx
DATA AND SAFETY MONITORING BOARD.pptxDATA AND SAFETY MONITORING BOARD.pptx
DATA AND SAFETY MONITORING BOARD.pptxPartha70
 
Ethical review process, mk sharma
Ethical review process, mk sharmaEthical review process, mk sharma
Ethical review process, mk sharmaSHARDA UNIVERSITY
 
Drug and safety monitoring board
Drug and safety  monitoring boardDrug and safety  monitoring board
Drug and safety monitoring boardRamakanth Gadepalli
 
Surgical_audit_&_research_mm (1).ppt
Surgical_audit_&_research_mm (1).pptSurgical_audit_&_research_mm (1).ppt
Surgical_audit_&_research_mm (1).pptSofiaJohn5
 
Ebm misconception myths facts
Ebm misconception myths factsEbm misconception myths facts
Ebm misconception myths factsAboubakr Elnashar
 
Levels of irb review july 16 2019
Levels of irb review july 16 2019Levels of irb review july 16 2019
Levels of irb review july 16 2019Weam Banjar
 
1670327194_887_Research_with_human_participation.pptx
1670327194_887_Research_with_human_participation.pptx1670327194_887_Research_with_human_participation.pptx
1670327194_887_Research_with_human_participation.pptxVelmaPranayReddy
 
Data and Safety Monitoring Board - An Overview
Data and Safety Monitoring Board - An OverviewData and Safety Monitoring Board - An Overview
Data and Safety Monitoring Board - An OverviewDr Sukanta sen
 
Roles and responsibilities in clinical trials
Roles and responsibilities in clinical trialsRoles and responsibilities in clinical trials
Roles and responsibilities in clinical trialsDRx Tejas Kanhed
 

Similar to Filtering Medical Research for Validity and Relevance (20)

Methodology Checklist : Studies of Diagnostic Accuracy
Methodology Checklist : Studies of Diagnostic AccuracyMethodology Checklist : Studies of Diagnostic Accuracy
Methodology Checklist : Studies of Diagnostic Accuracy
 
Surgical_audit_&_research_iagsisbbbuikbb
Surgical_audit_&_research_iagsisbbbuikbbSurgical_audit_&_research_iagsisbbbuikbb
Surgical_audit_&_research_iagsisbbbuikbb
 
Qi Irb Presentation
Qi Irb PresentationQi Irb Presentation
Qi Irb Presentation
 
PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...
PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...
PMED: APPM Workshop: Challenges in Using Bayesian Analysis Approaches for Reg...
 
DATA AND SAFETY MONITORING BOARD.pptx
DATA AND SAFETY MONITORING BOARD.pptxDATA AND SAFETY MONITORING BOARD.pptx
DATA AND SAFETY MONITORING BOARD.pptx
 
Ethical review process, mk sharma
Ethical review process, mk sharmaEthical review process, mk sharma
Ethical review process, mk sharma
 
Drug and safety monitoring board
Drug and safety  monitoring boardDrug and safety  monitoring board
Drug and safety monitoring board
 
Clinical research protocol
Clinical research protocolClinical research protocol
Clinical research protocol
 
Surgical_audit_&_research_mm (1).ppt
Surgical_audit_&_research_mm (1).pptSurgical_audit_&_research_mm (1).ppt
Surgical_audit_&_research_mm (1).ppt
 
Evidence based decision making
Evidence based decision makingEvidence based decision making
Evidence based decision making
 
Ebm misconception myths facts
Ebm misconception myths factsEbm misconception myths facts
Ebm misconception myths facts
 
Levels of irb review july 16 2019
Levels of irb review july 16 2019Levels of irb review july 16 2019
Levels of irb review july 16 2019
 
1670327194_887_Research_with_human_participation.pptx
1670327194_887_Research_with_human_participation.pptx1670327194_887_Research_with_human_participation.pptx
1670327194_887_Research_with_human_participation.pptx
 
Data and Safety Monitoring Board - An Overview
Data and Safety Monitoring Board - An OverviewData and Safety Monitoring Board - An Overview
Data and Safety Monitoring Board - An Overview
 
# 4th lect HSR
# 4th lect  HSR# 4th lect  HSR
# 4th lect HSR
 
CLINICAL RESERCH TEAM MEMBERS .pptx
CLINICAL RESERCH TEAM MEMBERS                .pptxCLINICAL RESERCH TEAM MEMBERS                .pptx
CLINICAL RESERCH TEAM MEMBERS .pptx
 
NOS
NOSNOS
NOS
 
Roles and responsibilities in clinical trials
Roles and responsibilities in clinical trialsRoles and responsibilities in clinical trials
Roles and responsibilities in clinical trials
 
Clinical trials
Clinical trialsClinical trials
Clinical trials
 
NOS SCALE.ppt
NOS SCALE.pptNOS SCALE.ppt
NOS SCALE.ppt
 

Recently uploaded

“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...RKavithamani
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 

Recently uploaded (20)

“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 

Filtering Medical Research for Validity and Relevance

  • 1.
  • 2. Information Article ◦ Received to published : 2 April 2018 ◦ Published in a manner on line : 22 May 2018 ◦ DOI: https://doi.org/10.1016/j.jotr.2018.05.003 ◦ Cost/endorsement :This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors, and no material support of any kind was received.
  • 3. Filtering to Validity Early and Relevance 1. Isthearticleapeer-reviewedjournal?No 2. Isthisresearchlocation,ifvalid,willbeusedforthebenefitofmypractice?Yes. 3. Whetherthisresearchissponsoredbyanorganizationthatmaybeinvolvedinthe designoftheresearchdata?No.
  • 4. Filtering to Validity Early and Relevance 4. Wouldthisinformation,iftrue,haveadirectimpactonthehealthofmypatientsand willitbemeaningfultothem?Yes. 5. Whetherthisproblemissomethingthatisfrequentlyencounteredinmyplaceof practice,andwhethertheinterventionortestcanbeusedandisavailableformeto use?Yes. 6. Wouldthisinformation,ifcorrect,leadmetochangemycurrentpractice?Yes.
  • 5. Level Therapy/Prevention, Aetiology/Harm Prognosis Diagnosis 1 a SR (with homogeneity*) of RCTs SR (with homogeneity*) of inception cohort studies: CDR± validated in different populations SR (with homogeneity*) of Level 1 diagnostic studies; CDR± with 1b studies from different clinical centres 1 b Individual RCT (with narrow Confidence Interval±) Individual inception cohort study with > 80% follow-up; CDR± validated in a single population Validating** cohort study with good±±± reference standards; or CDR± tested within one clinical centre 1 c All or none All or none case-series Absolute SpPins and SnNouts±± LEVEL 1 OF EVIDANCE
  • 6. Level Therapy/Prevention, Aetiology/Harm Prognosis Diagnosis 2 a SR (with homogeneity*) of cohort studies SR (with homogeneity*) of either retrospective cohort studies or untreated control groups in RCTs SR (with homogeneity*) of Level >2 diagnostic studies 2 b Individual cohort study (including low quality RCT; e.g., <80% follow- up) Retrospective cohort study or follow-up of untreated control patients in an RCT; Derivation of CDR± or validated on split- sample only Exploratory** cohort study with good±±± reference standards; CDR± after derivation, or validated only on split-sample or databases 2 c "Outcomes" Research; Ecological studies "Outcomes" Research LEVEL 2 OF EVIDENCE
  • 7. Level Therapy/Prevention, Aetiology/Harm Prognosis Diagnosis 3 a SR (with homogeneity*) of cohort studies SR (with homogeneity*) of 3b and better studies 3 b Individual Case-Control Study Non-consecutive study; or without consistently applied reference standards 4 Case-series (and poor quality cohort and case- control studies§§) Case-series (and poor quality prognostic cohort studies***) Case-control study, poor or non-independent reference standard 5 Expert opinion without explicit critical appraisal, or based on physiology, bench research or "first principles" Expert opinion without explicit critical appraisal, or based on physiology, bench research or "first principles" Expert opinion without explicit critical appraisal, or based on physiology, bench research or "first principles" LEVEL 3,4,5 OF EVIDENCE
  • 8. A consistent level 1 studies B consistent level 2 or 3 studies or extrapolations from level 1 studies C level 4 studies or extrapolations from level 2 or 3 studies D level 5 evidence or troublingly inconsistent or inconclusive studies pf any level GRADE OF RECOMENDATION